Denali Therapeutics Inc. (DNLI)

NASDAQ: DNLI · Real-Time Price · USD

14.93

-0.26 (-1.74%)

At close: Jun 12, 2025, 4:00 PM

15.67

+0.74 (4.99%)

After-hours: Jun 12, 2025, 7:15 PM EDT

Denali Therapeutics Market Cap

Denali Therapeutics has a market cap or net worth of $2.17 billion as of June 12, 2025. Its market cap has decreased by -20.85% in one year.

Market Cap

2.17B

Enterprise Value

1.17B

1-Year Change

-20.85%

Ranking

#1847

Market Cap Chart

Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $2.17B, an increase of 14.89%. That is a compound annual growth rate of 1.87%.

Market Cap History

Date	Market Cap	% Change
Jun 11, 2025	2.21B	-24.76%
Dec 31, 2024	2.93B	-1.10%
Dec 29, 2023	2.97B	-21.48%
Dec 30, 2022	3.78B	-30.66%
Dec 31, 2021	5.45B	-45.77%
Dec 31, 2020	10.04B	500.43%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	694.59B
Johnson & Johnson	373.49B
AbbVie	334.13B
Novo Nordisk	332.47B
UnitedHealth Group	275.04B
Abbott Laboratories	232.09B
Novartis AG	231.17B
AstraZeneca	226.45B

Market Cap Rankings